Glyceroltrinitrat Carinopharm

Glyceroltrinitrat Carinopharm contains the active ingredient glyceryl trinitrate in an intravenous formulation. It is a prescription‑only organic nitrate marketed in the European Union. The product delivers nitric‑oxide mediated vasodilation to reduce myocardial oxygen demand. While the exact strength is not specified, the preparation is used by healthcare professionals in acute care settings.

Glyceroltrinitrat Carinopharm is indicated for rapid relief of several acute cardiovascular conditions where prompt vasodilation is required.

- Acute angina pectoris, including episodes unresponsive to oral nitrates. - Acute decompensated heart failure with pulmonary congestion. - Hypertensive emergencies or severe hypertension requiring immediate reduction. - Controlled hypotension during surgical procedures.

Side effects of intravenous glyceryl trinitrate reflect its vasodilatory action and may vary in frequency.

Common: - Headache, often transient. - Flushing or warmth sensation. - Dizziness or light‑headedness. - Mild to moderate hypotension. - Reflex tachycardia.

Serious: - Severe hypotension leading to syncope. - Myocardial ischemia or infarction. - Life‑threatening arrhythmias. - Methemoglobinemia (rare).

When using Glyceroltrinitrat Carinopharm, clinicians should observe several precautions to minimise risk.

- Avoid in patients with known hypersensitivity to organic nitrates. - Contraindicated in severe anemia or increased intracranial pressure. - Use cautiously in patients taking phosphodiesterase‑5 inhibitors due to risk of profound hypotension. - Monitor blood pressure and heart rate continuously during infusion. - Adjust dose in elderly or patients with hepatic impairment. - Ensure adequate fluid status to prevent excessive blood pressure drop.

Glyceroltrinitrat Carinopharm can interact with other medications that affect vascular tone or cardiac function.

Avoid: - Phosphodiesterase‑5 inhibitors (e.g., sildenafil, tadalafil). - Other nitrate preparations or nitrites. - Strong antihypertensive agents (e.g., ACE inhibitors, ARBs) given concurrently.

Use with caution: - Beta‑blockers, which may mask tachycardia. - Diuretics, which can enhance hypotensive effect. - General anesthetics, especially those causing vasodilation.